Key result
High stress hyperglycemia ratio is linked to a ~152% increase in 28-day mortality in HF.
Why the study?
Current research lacks sufficient insight into the correlation between the stress hyperglycemia ratio and 28-day mortality in critically ill patients with heart failure and diabetes.
Does the stress hyperglycemia ratio predict 28-day mortality in critically ill patients with heart failure and diabetes?
Cohort (n=1,697)
No
Does the stress hyperglycemia ratio predict 28-day mortality in critically ill patients with heart failure and diabetes?
Hazard Ratio: 2.52 (95% CI 1.61–3.93)
Absolute Event Rate: 17.7% vs 7.3%
p-value: p=<0.001
In critically ill patients with heart failure and diabetes, the stress hyperglycemia ratio exhibits a parabolic association with 28-day all-cause mortality, with values above 1.0 significantly increasing mortality risk.
May flag high-risk critically ill HF patients with diabetes; leaves open whether SHR-guided care improves outcomes.
Current research lacks sufficient insight into the correlation between the stress hyperglycemia ratio (SHR) and 28-day mortality in critically ill patients with heart failure and diabetes. Our study aims to investigate this correlation. A total of 1697 critically ill patients with heart failure and diabetes were enrolled from the Medical Information Mart for Intensive Care IV 3.1 database. Logistic regression, Cox proportional hazards modeling, and smooth curve fitting analyses were used to meet the research objectives. The total rate of 28-day mortality was 12.1%. Multiple regression analysis showed that the hazard ratios for 28-day mortality in the lowest (Q1), middle (Q3), and highest (Q4) SHR quartiles were 1.85 (95% confidence interval [CI] = 1.17–2.92), 1.38 (95% CI = 0.84–2.20), and 2.52 (95% CI = 1.61–3.93), respectively. Moreover, a U-shaped relationship was found between SHR and mortality risk, with the lowest risk at an SHR of 1.0. Above this level, the hazard ratio increased to 1.707 (95% CI = 1.143–2.549, P = .009). Subgroup analysis revealed no other significant findings ( P > .05). In patients with heart failure and diabetes, SHR exhibits a parabolic association with 28-day all-cause mortality. Notably, an SHR value exceeding 1.0 is associated with a significantly increased risk of 28-day mortality.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) conducted a cohort in Heart failure and diabetes in critically ill patients (n=1,697). Stress hyperglycemia ratio (SHR) vs. Middle quartile (Q2) or SHR of 1.0 was evaluated on 28-day all-cause mortality (HR 2.52, 95% CI 1.61-3.93, p=<0.001). In critically ill patients with heart failure and diabetes, a stress hyperglycemia ratio in the highest quartile was associated with a significantly increased risk of 28-day all-cause mortality (HR 2.52) compared to the second quartile.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: